Real-time SEC alerts Start Free →
Profitelligence
West Pharmaceutical Services Inc.
WST HIGH Impact

West Pharmaceutical Services Inc.

West Pharmaceutical Services Discloses Material Cybersecurity Incident

| 8-K |Healthcare

Summary

On May 7, 2026, West Pharmaceutical Services, Inc. disclosed a material cybersecurity incident where certain data was exfiltrated and systems were encrypted. The company detected the intrusion on May 4, 2026, and activated its incident response protocols, including taking systems offline globally, notifying law enforcement, and engaging external cyber-forensic experts. The incident has temporarily disrupted business operations globally, although some critical processes have restarted. The financial impact is yet to be determined. West is leveraging its business continuity plans and working with customers to mitigate risk and minimize delays.

Profitelligence Profitelligence Alerts

Get alerts for WST

Be first to know when West Pharmaceutical Services Inc. files with the SEC.

Set Up Alerts →

Filing Categories

Material Agreement Amendment Regulatory Investigation Major Legal Settlement

Advertisement

About West Pharmaceutical Services Inc.

West Pharmaceutical Services Inc. is a leading global provider of innovative solutions for injectable drug administration. The company specializes in designing and manufacturing packaging and delivery systems specifically for pharmaceuticals, biologics, and vaccines. West Pharmaceutical Services plays a crucial role in ensuring the safety and efficiency of drug delivery through its products, which include stoppers, seals, containers, and pre-fillable syringe systems. Catering to a diverse range of healthcare and pharmaceutical clients, the company's offerings are integral in the development and distribution of injectable therapies across various therapeutic categories, including oncology, diabetes, and infectious diseases. As a partner to some of the world's leading pharmaceutical companies, West Pharmaceutical Services contributes significantly to advancements in medical treatments and healthcare technologies globally. Its commitment to quality and innovation underscores its importance in the pharmaceutical supply chain and enhances drug efficacy, ultimately impacting patient care and treatment outcomes.

Exchange: NYSE Industry: Medical Instruments & Supplies Company Website →

Official SEC Documents

WST
WST Research
8Ks, insider trades, financials, technicals
SEC Alert Manager
Get alerts within 60 seconds of new filings

Advertisement